Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain

[1]  F. Carinci,et al.  New Approach to Chronic Back Pain Treatment: A Case Control Study , 2022, Biomedicines.

[2]  J. Eschweiler,et al.  Acupuncture in chronic aspecific low back pain: a Bayesian network meta-analysis , 2022, Journal of Orthopaedic Surgery and Research.

[3]  J. Todri,et al.  A randomized controlled trial concerning the implementation of the postural Mézières treatment in elite athletes with low back pain , 2022, Postgraduate medicine.

[4]  Xiaodong Feng,et al.  Observation of curative effect on meridian theory-based extracorporeal shock wave therapy for non-specific low back pain: study protocol for a randomized controlled trial , 2022, Journal of Orthopaedic Surgery and Research.

[5]  F. Carinci,et al.  Oxygen–Ozone Therapy Associated with Alpha Lipoic Acid Plus Palmitoylethanolamide and Myrrh versus Ozone Therapy in the Combined Treatment of Sciatic Pain Due to Herniated Discs: Observational Study on 318 Patients , 2022, International journal of environmental research and public health.

[6]  J. Baeza-Noci,et al.  Updated Review on Ozone Therapy in Pain Medicine , 2022, Frontiers in Physiology.

[7]  Y. Delpierre.  Fear-avoidance beliefs, anxiety and depression are associated with motor control and dynamics parameters in patients with chronic low back pain. , 2022, Journal of orthopaedics.

[8]  Michael J. Schneider,et al.  Interventions for the Management of Acute and Chronic Low Back Pain: Revision 2021. , 2021, The Journal of orthopaedic and sports physical therapy.

[9]  L. Macedo,et al.  Prevalence, incidence, and factors associated with non-specific chronic low back pain in community-dwelling older adults aged 60 years and older: A systematic review and meta-analysis. , 2021, The journal of pain.

[10]  S. Schabrun,et al.  Efficacy, acceptability, and safety of muscle relaxants for adults with non-specific low back pain: systematic review and meta-analysis , 2021, BMJ.

[11]  Anmin Jin,et al.  Gene correlation network analysis to identify regulatory factors in sciatic nerve injury , 2021, Journal of Orthopaedic Surgery and Research.

[12]  M. Koleck,et al.  Clinical guidelines and care pathway for management of low back pain with or without radicular pain. , 2021, Joint bone spine.

[13]  J. Eschweiler,et al.  Non-steroidal anti-inflammatory drugs and gabapentinoids for chronic lumbar pain: a Bayesian network meta-analysis of randomized controlled trials. , 2021, British medical bulletin.

[14]  J. Eschweiler,et al.  Opioids for chronic low back pain management: a Bayesian network meta-analysis , 2021, Expert review of clinical pharmacology.

[15]  Charles H. Cho,et al.  Corrigendum to "Guideline summary review: an evidence-based clinical guideline for the diagnosis and treatment of low back pain" [The Spine Journal 20/7 (2020) p 998-1024]. , 2021, The spine journal : official journal of the North American Spine Society.

[16]  N. Maffulli,et al.  Management of facet joints osteoarthritis associated with chronic low back pain: A systematic review. , 2021, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[17]  C. Maher,et al.  Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis , 2021, BMJ.

[18]  Yunze Li,et al.  Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial , 2020, Journal of Orthopaedic Surgery and Research.

[19]  J. Eschweiler,et al.  Ozone injection therapy for intervertebral disc herniation. , 2020, British medical bulletin.

[20]  D. A. van der Windt,et al.  Evidence‐based treatment recommendations for neck and low back pain across Europe: A systematic review of guidelines , 2020, European journal of pain.

[21]  C. Maher,et al.  Emergency department interventions for adult patients with low back pain: a systematic review of randomised controlled trials , 2020, Emergency Medicine Journal.

[22]  J. Eschweiler,et al.  The pharmacological management of chronic lower back pain , 2020, Expert opinion on pharmacotherapy.

[23]  J. Ahlner,et al.  Current Evidence on Abuse and Misuse of Gabapentinoids , 2020, Drug Safety.

[24]  Charles H. Cho,et al.  Guideline summary review: An evidence-based clinical guideline for the diagnosis and treatment of low back pain. , 2020, The spine journal : official journal of the North American Spine Society.

[25]  A. Desomer,et al.  The Belgian national guideline on low back pain and radicular pain: key roles for rehabilitation, assessment of rehabilitation potential and the PRM specialist. , 2020, European journal of physical and rehabilitation medicine.

[26]  J. Macdermid,et al.  Psychometric properties of the global rating of change scales in patients with low back pain, upper and lower extremity disorders. A systematic review with meta-analysis. , 2020, Journal of Orthopaedics.

[27]  T. Khong,et al.  No benefit from amitriptyline for chronic low back pain? , 2020, Drug and Therapeutics Bulletin.

[28]  G. Varrassi,et al.  Combination of Rehabilitative Therapy with Ultramicronized Palmitoylethanolamide for Chronic Low Back Pain: An Observational Study , 2019, Pain and Therapy.

[29]  A. Oliviero,et al.  The temporal effect of intra-articular ozone injections on pain in knee osteoarthritis. , 2019, British medical bulletin.

[30]  A. Marques,et al.  Prevalence of low back pain in the elderly population: a systematic review , 2019, Clinics.

[31]  A. Espeland,et al.  Efficacy of antibiotic treatment in patients with chronic low back pain and Modic changes (the AIM study): double blind, randomised, placebo controlled, multicentre trial , 2019, BMJ.

[32]  K. Tillisch,et al.  VA/DoD Clinical Practice Guideline: Diagnosis and Treatment of Low Back Pain , 2019, Journal of General Internal Medicine.

[33]  E. Gallagher,et al.  A Randomized, Placebo-Controlled Trial of Ibuprofen Plus Metaxalone, Tizanidine, or Baclofen for Acute Low Back Pain. , 2019, Annals of emergency medicine.

[34]  K. Song,et al.  Gabapentin versus Transdermal Fentanyl Matrix for the Alleviation of Chronic Neuropathic Pain of Radicular Origin: A Randomized Blind Multicentered Parallel-Group Noninferiority Trial , 2019, Pain research & management.

[35]  J. Eschweiler,et al.  Autogenic mesenchymal stem cells for intervertebral disc regeneration , 2018, International Orthopaedics.

[36]  F. Cicuttini,et al.  Efficacy of Low-Dose Amitriptyline for Chronic Low Back Pain: A Randomized Clinical Trial , 2018, JAMA internal medicine.

[37]  E. Shipton.  Physical Therapy Approaches in the Treatment of Low Back Pain , 2018, Pain and Therapy.

[38]  C. Maher,et al.  Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis , 2018, Canadian Medical Association Journal.

[39]  E. Cione,et al.  N‐Palmitoyl Ethanol Amide Pharmacological Treatment in Patients With Nonsurgical Lumbar Radiculopathy , 2018, Journal of clinical pharmacology.

[40]  Martin Underwood,et al.  Prevention and treatment of low back pain: evidence, challenges, and promising directions , 2018, The Lancet.

[41]  L. Arendt-Nielsen,et al.  Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial , 2018, PloS one.

[42]  H. Younus.  Therapeutic potentials of superoxide dismutase , 2018, International journal of health sciences.

[43]  K. Kroenke,et al.  Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial , 2018, JAMA.

[44]  O. Gabbar,et al.  Lumbar facet joint injection in treating low back pain: Radiofrequency denervation versus SHAM procedure. Systematic review. , 2018, Journal of orthopaedics.

[45]  M. Nordin,et al.  The Global Spine Care Initiative: applying evidence-based guidelines on the non-invasive management of back and neck pain to low- and middle-income communities , 2018, European Spine Journal.

[46]  M. Nazıroğlu,et al.  Neuropathic Pain: Delving into the Oxidative Origin and the Possible Implication of Transient Receptor Potential Channels , 2018, Front. Physiol..

[47]  L. Arendt-Nielsen,et al.  Predicting drug efficacy in chronic low back pain by quantitative sensory tests , 2018, European journal of pain.

[48]  Marc Russo,et al.  Muscle Control and Non‐specific Chronic Low Back Pain , 2017, Neuromodulation : journal of the International Neuromodulation Society.

[49]  H. Flor,et al.  Placebo effects of a sham opioid solution: a randomized controlled study in patients with chronic low back pain , 2017, Pain.

[50]  W. Andrzejewski,et al.  Recommendations of the Polish Society of Physiotherapy, the Polish Society of Family Medicine and the College of Family Physicians in Poland in the field of physiotherapy of back pain syndromes in primary health care , 2017 .

[51]  André Krath,et al.  Electromagnetic transduction therapy in non-specific low back pain: A prospective randomised controlled trial. , 2017, Journal of orthopaedics.

[52]  Soumitra Das,et al.  Baclofen and Back Pain: A Paradoxical Phenomena , 2017, Indian journal of psychological medicine.

[53]  C. Maher,et al.  Diagnostic triage for low back pain: a practical approach for primary care , 2017, The Medical journal of Australia.

[54]  N. Takahashi,et al.  Therapeutic efficacy of nonsteroidal anti-inflammatory drug therapy versus exercise therapy in patients with chronic nonspecific low back pain: a prospective study. , 2017, Fukushima journal of medical science.

[55]  S. Moon,et al.  Efficacy and Safety of Different Aceclofenac Treatments for Chronic Lower Back Pain: Prospective, Randomized, Single Center, Open-Label Clinical Trials , 2017, Yonsei medical journal.

[56]  S. Ward,et al.  Low back pain and sciatica: summary of NICE guidance , 2017, British Medical Journal.

[57]  Judith Jones,et al.  The aging population: demographics and the biology of aging. , 2016, Periodontology 2000.

[58]  Kylie A. Williams,et al.  Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis. , 2016, JAMA internal medicine.

[59]  S. Matthews,et al.  A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component , 2016, Pain.

[60]  S. Montella,et al.  Mechanisms of low back pain: a guide for diagnosis and therapy , 2016, F1000Research.

[61]  Roger Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. , 2016, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[62]  R. Chou,et al.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.

[63]  G. Heinze,et al.  Efficacy of Duloxetine in Chronic Low Back Pain with a Neuropathic Component: A Randomized, Double-blind, Placebo-controlled Crossover Trial , 2016, Anesthesiology.

[64]  A. Fassa,et al.  Prevalence of chronic low back pain: systematic review , 2015, Revista de saude publica.

[65]  D. Wallis,et al.  Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled Trial , 2015, Arthritis care & research.

[66]  R. Baron,et al.  Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study , 2015, Pain practice : the official journal of World Institute of Pain.

[67]  B. Turner,et al.  Assessing risk for drug overdose in a national cohort: role for both daily and total opioid dose? , 2015, The journal of pain : official journal of the American Pain Society.

[68]  Kelly Cho,et al.  Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. , 2015, JAMA internal medicine.

[69]  Qianrui Li,et al.  Acetyl-L-Carnitine in the Treatment of Peripheral Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2015, PloS one.

[70]  R. Ostelo,et al.  Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis , 2015, BMJ : British Medical Journal.

[71]  Y. Sakai,et al.  Pharmacological management of chronic low back pain in older patients: a randomized controlled trial of the effect of pregabalin and opioid administration , 2015, European Spine Journal.

[72]  F. Cicuttini,et al.  Could low grade bacterial infection contribute to low back pain? A systematic review , 2015, BMC Medicine.

[73]  D. Carpenter,et al.  Elucidating risk factors for androgen deficiency associated with daily opioid use. , 2014, The American journal of medicine.

[74]  Pradeep Rajan,et al.  Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. , 2014, Pain medicine.

[75]  R. Jamison,et al.  Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers. , 2014, Journal of opioid management.

[76]  D. Beckwée,et al.  Applying modern pain neuroscience in clinical practice: criteria for the classification of central sensitization pain. , 2014, Pain physician.

[77]  Todd M. Moore,et al.  Further validation of an opioid risk assessment tool: the Brief Risk Interview. , 2014, Journal of opioid management.

[78]  R. Day,et al.  Efficacy of paracetamol for acute low-back pain: a double-blind, randomised controlled trial , 2014, BDJ.

[79]  M. Meeus,et al.  Treatment of central sensitization in patients with ‘unexplained’ chronic pain: an update , 2014, Expert opinion on pharmacotherapy.

[80]  Caleb Wiedeman,et al.  High-risk use by patients prescribed opioids for pain and its role in overdose deaths. , 2014, JAMA internal medicine.

[81]  S. Atlas,et al.  Opioids Compared With Placebo or Other Treatments for Chronic Low Back Pain: An Update of the Cochrane Review , 2014, Spine.

[82]  C. Crawford,et al.  Multimodal, integrative therapies for the self-management of chronic pain symptoms. , 2014, Pain medicine.

[83]  L. Facci,et al.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain , 2014, Inflammopharmacology.

[84]  R. Chou,et al.  Opioid Prescribing: A Systematic Review and Critical Appraisal of Guidelines for Chronic Pain , 2014, Annals of Internal Medicine.

[85]  P. Wiffen,et al.  Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. , 2014, The Cochrane database of systematic reviews.

[86]  Pablo Alonso-Coello,et al.  Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks , 2014, Implementation Science.

[87]  B. Martin,et al.  The Role of Opioid Prescription in Incident Opioid Abuse and Dependence Among Individuals With Chronic Noncancer Pain: The Role of Opioid Prescription , 2013, The Clinical journal of pain.

[88]  A. Albanese,et al.  Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain. , 2013, European journal of physical and rehabilitation medicine.

[89]  R. Oostendorp,et al.  Central Sensitization and Altered Central Pain Processing in Chronic Low Back Pain: Fact or Myth? , 2013, The Clinical journal of pain.

[90]  Amanda F. Petrik,et al.  Prescription Opioids for Back Pain and Use of Medications for Erectile Dysfunction , 2013, Spine.

[91]  H. Cabral,et al.  Opioid use for noncancer pain and risk of myocardial infarction amongst adults , 2013, Journal of internal medicine.

[92]  D. Redelmeier,et al.  Opioid dose and risk of road trauma in Canada: a population-based study. , 2013, JAMA internal medicine.

[93]  C. Terwee,et al.  Spinal Manipulative Therapy for Acute Low Back Pain: An Update of the Cochrane Review , 2013, Spine.

[94]  Christopher Eccleston,et al.  Psychological therapies for the management of chronic pain (excluding headache) in adults. , 2012, The Cochrane database of systematic reviews.

[95]  Bernd Terhaag,et al.  Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study , 2012, Current medical research and opinion.

[96]  M. Angst,et al.  Analgesic tolerance without demonstrable opioid-induced hyperalgesia: A double-blinded, randomized, placebo-controlled trial of sustained-release morphine for treatment of chronic nonradicular low-back pain , 2012, PAIN®.

[97]  A. Staines,et al.  Self-reported pain severity, quality of life, disability, anxiety and depression in patients classified with 'nociceptive', 'peripheral neuropathic' and 'central sensitisation' pain. The discriminant validity of mechanisms-based classifications of low back (±leg) pain. , 2012, Manual therapy.

[98]  M. Dewood,et al.  A Double-Blind Controlled Trial of a Single Dose Naproxen and an Amino Acid Medical Food Theramine for the Treatment of Low Back Pain , 2012, American journal of therapeutics.

[99]  B. Terhaag,et al.  Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain - results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials. , 2011, International journal of clinical pharmacology and therapeutics.

[100]  L. Reisner.  Pharmacological management of persistent pain in older persons. , 2011, The journal of pain : official journal of the American Pain Society.

[101]  C. Woolf.  Central sensitization: Implications for the diagnosis and treatment of pain , 2011, PAIN.

[102]  M. Egger,et al.  Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis , 2011, BMJ : British Medical Journal.

[103]  F. Violante,et al.  Effectiveness of a 'Global Postural Reeducation' program for persistent Low Back Pain: a non-randomized controlled trial , 2010, BMC musculoskeletal disorders.

[104]  T. Miazgowski,et al.  Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. , 2010, The journal of pain : official journal of the American Pain Society.

[105]  L. Re,et al.  Clinical evidence of ozone interaction with pain mediators. , 2010, Saudi medical journal.

[106]  Joseph A Boscarino,et al.  Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. , 2010, Addiction.

[107]  David Yarnitsky,et al.  Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states , 2010, Current opinion in anaesthesiology.

[108]  C. Rauschkolb,et al.  Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study , 2010, Expert opinion on pharmacotherapy.

[109]  L. Macedo,et al.  An updated overview of clinical guidelines for the management of non-specific low back pain in primary care , 2010, European Spine Journal.

[110]  M. Detke,et al.  Efficacy and Safety of Duloxetine in Patients With Chronic Low Back Pain , 2010, Spine.

[111]  Christopher G. Maher,et al.  Exercise for Osteoarthritis of the Knee , 2010, Physical Therapy.

[112]  S. Rashiq,et al.  Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. , 2010, Clinical therapeutics.

[113]  M. Backonja,et al.  Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. , 2010, Pain medicine.

[114]  R. Oostendorp,et al.  Recognition of central sensitization in patients with musculoskeletal pain: Application of pain neurophysiology in manual therapy practice. , 2010, Manual therapy.

[115]  S. Tregear,et al.  Long-term opioid management for chronic noncancer pain. , 2010, The Cochrane database of systematic reviews.

[116]  C. Romanò,et al.  Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain , 2009, Journal of Orthopaedics and Traumatology.

[117]  D. Boudreau,et al.  Opioid use behaviors, mental health and pain--development of a typology of chronic pain patients. , 2009, Drug and alcohol dependence.

[118]  R. Panush,et al.  Back pain made simple: An approach based on principles and evidence , 2009, Cleveland Clinic Journal of Medicine.

[119]  S. Asch,et al.  Development and Initial Validation of the PEG, a Three-item Scale Assessing Pain Intensity and Interference , 2009, Journal of General Internal Medicine.

[120]  B. van Houdenhove,et al.  From acute musculoskeletal pain to chronic widespread pain and fibromyalgia: application of pain neurophysiology in manual therapy practice. , 2009, Manual therapy.

[121]  C. Maihöfner,et al.  Central mechanisms of experimental and chronic neuropathic pain: Findings from functional imaging studies , 2009, Cellular and Molecular Life Sciences.

[122]  M. Meeus,et al.  Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: An experimental study , 2008, PAIN.

[123]  A. Kurenkov,et al.  Evidence of persistent central sensitization in chronic headaches: a multi-method study , 2008, The Journal of Headache and Pain.

[124]  S. Datta,et al.  Opioid complications and side effects. , 2008, Pain physician.

[125]  J. Hoving,et al.  Antidepressants for non-specific low back pain. , 2008, The Cochrane database of systematic reviews.

[126]  R. Deyo,et al.  Nonsteroidal Anti-Inflammatory Drugs for Low Back Pain: An Updated Cochrane Review , 2008, The Cochrane database of systematic reviews.

[127]  Peter Croft,et al.  Interpreting Change Scores for Pain and Functional Status in Low Back Pain: Towards International Consensus Regarding Minimal Important Change , 2008, Spine.

[128]  P. Shekelle,et al.  Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society , 2007, Annals of Internal Medicine.

[129]  R. Rauck,et al.  Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. , 2007, The journal of pain : official journal of the American Pain Society.

[130]  Nathaniel Katz,et al.  A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain* , 2007, Current medical research and opinion.

[131]  L. Burns,et al.  Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain. , 2006, The journal of pain : official journal of the American Pain Society.

[132]  S. Perrot,et al.  Efficacy and tolerability of paracetamol/tramadol (325 mg/37.5 mg) combination treatment compared with tramadol (50 mg) monotherapy in patients with subacute low back pain: a multicenter, randomized, double-blind, parallel-group, 10-day treatment study. , 2006, Clinical therapeutics.

[133]  L. Laine,et al.  Systematic review: the lower gastrointestinal adverse effects of non‐steroidal anti‐inflammatory drugs , 2006, Alimentary pharmacology & therapeutics.

[134]  Peter K. Leiberich,et al.  Topiramate in Treatment of Patients With Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled Study , 2006, The Clinical journal of pain.

[135]  M. Wallen,et al.  Intra-articular steroids and splints/rest for children with juvenile idiopathic arthritis and adults with rheumatoid arthritis. , 2006, The Cochrane database of systematic reviews.

[136]  M. Max,et al.  Topiramate in chronic lumbar radicular pain. , 2005, The journal of pain : official journal of the American Pain Society.

[137]  Karen Simpson,et al.  Transdermal Fentanyl Versus Sustained Release Oral Morphine in Strong-Opioid Naïve Patients With Chronic Low Back Pain , 2005, Spine.

[138]  M. Shivaprakash,et al.  Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study , 2005, Current medical research and opinion.

[139]  R. D. Hetzel,et al.  A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. , 2005, The journal of pain : official journal of the American Pain Society.

[140]  B. Koes,et al.  Exercise therapy for treatment of non-specific low back pain. , 2005, The Cochrane database of systematic reviews.

[141]  H. Shannon,et al.  Efficacy of Duloxetine, a Potent and Balanced Serotonergic and Noradrenergic Reuptake Inhibitor, in Inflammatory and Acute Pain Models in Rodents , 2005, Journal of Pharmacology and Experimental Therapeutics.

[142]  D. Borenstein,et al.  Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial. , 2004, Clinical therapeutics.

[143]  A. Mangione,et al.  Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial. , 2003, The journal of pain : official journal of the American Pain Society.

[144]  R. Karim,et al.  Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. , 2003, Clinical therapeutics.

[145]  R. Buchbinder,et al.  Corticosteroid injections for shoulder pain. , 2003, The Cochrane database of systematic reviews.

[146]  A. Basbaum,et al.  Molecular mechanisms of nociception , 2001, Nature.

[147]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[148]  P. Isakson,et al.  Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison , 1999, The Lancet.

[149]  T. Patterson,et al.  Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity , 1999, PAIN.

[150]  J. Krainick,et al.  [Flupirtine in comparison with chlormezanone in chronic musculoskeletal back pain. Results of a multicenter randomized double-blind study]. , 1996, Fortschritte der Medizin.

[151]  K. Seibert,et al.  Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[152]  Iasp Subcommittee on Taxonomy.  Pain terms a current list with definitions and notes on usage , 1986, Pain.

[153]  S. Azen,et al.  Amitriptyline and Chronic Low-Back Pain: A Randomized Double-Blind Crossover Study , 1983, Spine.

[154]  Darren A. Rivett,et al.  Nonspecific Low Back Pain , 2019, Clinical Reasoning in Musculoskeletal Practice.

[155]  L. Marshman,et al.  Effect of Gabapentin vs Pregabalin on Pain Intensity in Adults With Chronic Sciatica: A Randomized Clinical Trial , 2019, JAMA neurology.

[156]  D. Morgan,et al.  2017 Update on Medical Overuse: A Systematic Review , 2018, JAMA internal medicine.

[157]  J. Vlaeyen,et al.  Low back pain and radicular pain : assessment and management , 2017 .

[158]  Mette Jensen Stochkendahl,et al.  National Clinical Guidelines for non-surgical treatment of patients with recent onset low back pain or lumbar radiculopathy , 2017, European Spine Journal.

[159]  R. Smeets,et al.  Low back pain: guidelines for the clinical classification of predominant neuropathic, nociceptive, or central sensitization pain. , 2015, Pain physician.

[160]  A. Starkweather,et al.  Low back pain. , 2015, Nursing.

[161]  V. Leinonen,et al.  [Update on Current Care Guideline: Low back pain]. , 2015, Duodecim; laaketieteellinen aikakauskirja.

[162]  Masato Tanaka,et al.  Efficacy of tramadol–acetaminophen tablets in low back pain patients with depression , 2015, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.

[163]  M. Elleuch,et al.  [Formalized consensus: clinical practice recommendations for the management of acute low back pain of the African patient]. , 2015, The Pan African medical journal.

[164]  C. Klötzsch,et al.  Leitlinien für Diagnostik und Therapie in der Neurologie , 2012 .

[165]  K. Raphael,et al.  Temporal summation of heat pain in temporomandibular disorder patients. , 2009, Journal of orofacial pain.

[166]  S. Mcconnell,et al.  Exercise for osteoarthritis of the hip. , 2009, The Cochrane database of systematic reviews.

[167]  D. Borenstein.  Epidemiology, etiology, diagnostic evaluation, and treatment of low back pain. , 1998, Current opinion in rheumatology.

[168]  B. Biehl.  [The effect of the analgesic flupirtine on automobile driving]. , 1985, Arzneimittel-Forschung.